ERIN GOTTMAN: Open Payments
NPI 1083711667 · PADUCAH, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$992 in 67 payments from 20 companies in 2025. Trend: 2023 $792 · 2024 $919 · 2025 $992
Food & beverage: $992
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $258 |
| Axsome Therapeutics, Inc. | 6 | $111 |
| Novo Nordisk Inc | 6 | $103 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $72 |
| AstraZeneca Pharmaceuticals LP | 4 | $59 |
| PFIZER INC. | 3 | $53 |
| Insulet Corporation | 3 | $51 |
| Lilly USA, LLC | 3 | $42 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $30 |
Products named: VRAYLAR, Auvelity, CAPLYTA, Ozempic, UBRELVY, QULIPTA, Omnipod, MOUNJARO.
Industry payments across KY — which companies pay providers there.
